⚠ Tool for educational and informational purposes only — not investment advice or a recommendation to buy or sell. Investing carries risk of capital loss. Read the full disclaimer.

SY — So-Young International Inc.

Last scan (Sept. 18, 2026): price $2.78, RSI 61.95, relative volume 0.29x, MACD ⚪ No, score 60.48.

It's in a bullish underlying trend (above its 200-day average), with an RSI of 61.95 in a neutral zone. Neither the MACD nor a range breakout gives a technical entry signal right now. Relative volume of 0.29x is below normal — little interest today. The analysts' average target price implies +162.9% upside — one of the score's strongest signals.

back to scanner

Price chart

Price: $2.76 · RSI (14): 41.68 · Rel. volume: 2.49x · Breakout: No

You can zoom by dragging a rectangle over the chart, or with your mouse wheel. Double-click to reset the view.

What analysts say

SY

So-Young International Inc. Healthcare · Health Information Services

So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China. The company offers So-Young Mobile App that offers users access to medical aesthetic knowledge, community support and reservation options for treatment with medical professionals, and medical…

Strong buy score 1.0/5 (1 = strong buy, 5 = sell)
2 analysts
  • Buy 2 (100.0%)
  • Hold 0 (0.0%)
  • Sell 0 (0.0%)

Average target price: $7.31 (+166.0% vs. current price) · range $5.01 – $9.62

Healthy Moderate Attention No data

Market cap $276.69M

Total market value of the company (price × shares outstanding).

P/E (trailing) N/A

P/E (trailing): compares the stock's price with its earnings per share over the last 12 months — how many times that earning is being paid for.

Not enough data to calculate it (no recent earnings or data unavailable).

P/E (forward) -37.99

P/E (forward): same as P/E, but using analysts' estimated earnings per share for the next year.

Same as P/E, using estimated future earnings.

PEG N/A

PEG: the P/E divided by the expected earnings growth rate — relates how expensive the stock is to how fast it's expected to grow.

Not enough data (requires future growth estimates).

Debt/Equity 23.65%

Debt/Equity: how much debt the company carries per dollar of shareholder equity — measures how leveraged the balance sheet is.

Low leverage: conservative balance sheet, less risk if interest rates rise.

Net margin -15.57%

Net margin: what percentage of each dollar of revenue ends up as net profit, after all costs.

Low margin: the business has little cushion if costs rise.

Dividend N/A

Dividend: what percentage of the stock's price is paid out in cash to shareholders each year.

Doesn't pay dividends: reinvests earnings into growth instead of distributing them.

Beta (risk) 2.13

Beta: how volatile the stock is compared to the overall market (S&P 500 = 1.0).

More volatile than the market: higher potential gain, but also higher potential loss.

General reference ranges, do not vary by sector. Third-party data; may be incomplete. Not investment advice.

💰 Financial Statements (last 3 quarters)

💰 Financial Statements (last 3 quarters)

Advertisement

What this chart shows

Third-party market data, for informational purposes. Not investment advice — read the disclaimer.